CBS and colonic neoplasm: Given these observations, in the attempt to characterize the molecular mechanism underlying rpL3-mediated cell response to 5-FU chemotherapy in colon cancer, we have investigated the existence of a regulatory mechanism of CBS expression mediated by rpL3.